Dr. Robert Montgomery, a leading surgeon, has initiated a groundbreaking clinical trial to transplant gene-edited pig kidneys into living humans. The first surgery has already been performed, with more planned for January, aiming for six patients initially. If approved by the FDA, the trial could expand to forty-four more transplants. These pig organs have been modified in ten spots to reduce rejection risks, aiming to tackle the severe organ shortage that has led to thousands of deaths in the UK alone. Montgomery, who has personal experience with heart transplants, is also exploring other solutions like chain donations and using organs from hepatitis C donors. Early tests have shown promising results, with no instant rejection in a brain-dead patient and two living individuals still having functional pig kidneys. Montgomery believes pig hearts and kidneys are promising, though lungs and livers pose more challenges. He wouldnt hesitate to accept a pig heart if necessary, expressing confidence that these advancements will ultimately alleviate the transplant crisis.

The Daily News Now! — Every city. Every story. AI-powered.

---

Hosted on Acast. See acast.com/privacy for more information.